DOI: 10.2337/dc06-0145 © 2006 by the American Diabetes Association
The Metabolic Syndrome Is Frequent in Klinefelters Syndrome and Is Associated With Abdominal Obesity and Hypogonadism
1 Medical Department M, Endocrinology and Diabetes, and Medical Research Laboratories, Clinical Institute, Aarhus University Hospital, Aarhus, Denmark Address correspondence and reprint requests to Anders Bojesen, MD, Medical Department M, Endocrinology and Diabetes, Aarhus University Hospital, Noerrebrogade 42-44, DK-8000, Aarhus C, Denmark. E-mail: anders.bojesen{at}dadlnet.dk OBJECTIVEKlinefelters syndrome is associated with an increased prevalence of diabetes, but the pathogenesis is unknown. Accordingly, the aim of this study was to investigate measures of insulin sensitivity, the metabolic syndrome, and sex hormones in patients with Klinefelters syndrome and an age-matched control group. RESEARCH DESIGN AN METHODSIn a cross-sectional study, we examined 71 patients with Klinefelters syndrome, of whom 35 received testosterone treatment, and 71 control subjects. Body composition was evaluated using dual-energy X-ray absorptiometry scans. Fasting blood samples were analyzed for sex hormones, plasma glucose, insulin, C-reactive protein (CRP), and adipocytokines. We analyzed differences between patients with untreated Klinefelters syndrome and control subjects and subsequently analyzed differences between testosterone-treated and untreated Klinefelters syndrome patients. RESULTSOf the patients with Klinefelters syndrome, 44% had metabolic syndrome (according to National Cholesterol Education Program/Adult Treatment Panel III criteria) compared with 10% of control subjects. Insulin sensitivity (assessed by homeostasis model assessment 2 modeling), androgen, and HDL cholesterol levels were significantly decreased, whereas total fat mass and LDL cholesterol, triglyceride, CRP, leptin, and fructosamine levels were significantly increased in untreated Klinefelters syndrome patients. In treated Klinefelters syndrome patients, LDL cholesterol and adiponectin were significantly decreased, whereas no difference in body composition was found in comparison with untreated Klinefelters syndrome patients. Multivariate analyses showed that truncal fat was the major determinant of metabolic syndrome and insulin sensitivity. CONCLUSIONSThe prevalence of metabolic syndrome was greatly increased, whereas insulin sensitivity was decreased in Klinefelters syndrome. Both correlated with truncal obesity. Hypogonadism in Klinefelters syndrome may cause an unfavorable change in body composition, primarily through increased truncal fat and decreased muscle mass. Testosterone treatment in Klinefelters syndrome only partly corrected the unfavorable changes observed in untreated Klinefelters syndrome, perhaps due to insufficient testosterone doses.
Abbreviations: ATPIII, Adult Treatment Panel III BFtr, truncal fat CRP, C-reactive protein DEXA, dual-energy X-ray absorptiometry FPG, fasting plasma glucose FSH, follicle-stimulating hormone HOMA, homeostasis model assessment HOMA2%S, HOMA of insulin sensitivity IMAT, intermuscular adipose tissue LBM, lean body mass LH, luteinizing hormone NCEP, National Cholesterol Education Program SHBG, sex hormonebinding globulin SMM, skeletal muscle mass TBF, total body fat
This article has been cited by other articles:
|
|
|
|||||||||||||||||||||||||||||||||||||||